Advances in Skeletal Dysplasia Genetics

Annual Review of Genomics and Human Genetics

Volumn 16, Issue , 2015, Pages 199-227

  Geister, Krista A ^a   Camper, Sally A ^a,b  

^a Department of Human Genetics ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Ciliopathy; Epigenetics; Growth insufficiency; Imprinting; Mosaicism; Primordial dwarfism

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HISTONE ACETYLTRANSFERASE; MICRORNA; NATRIURETIC PEPTIDE TYPE C; NOTCH RECEPTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ACHONDROPLASIA; BODY HEIGHT; BONE DEVELOPMENT; BONE DYSPLASIA; BONE GROWTH; BONE MATRIX; BONE MINERALIZATION; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CONGENITAL BONE DISEASE; DWARFISM; ENCHONDRAL OSSIFICATION; EPIGENETICS; GENE MUTATION; GENOME IMPRINTING; GROWTH DISORDER; HIGH THROUGHPUT SEQUENCING; HUMAN; IDIOPATHIC DISEASE; INTRAUTERINE GROWTH RESTRICTION METAPHYSEAL DYSPLASIA ADRENAL HYPOPLASIA CONGENITA ANG GENITAL ABNORMALITY SYNDROME; MOLECULAR PATHOLOGY; MOSAICISM; MULTIPLE CANCER; NONHUMAN; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PRIMORDIAL DWARFISM; REVIEW; SECKEL SYNDROME; SHORT STATURE; SKELETAL CILIOPATHY; SOMATIC MUTATION; WNT SIGNALING PATHWAY; ANIMAL; CHONDRODYSPLASIA; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; MOUSE; MUTATION; PROCEDURES;

ANIMALS; BODY HEIGHT; BONE DISEASES, DEVELOPMENTAL; DISEASE MODELS, ANIMAL; DWARFISM; EPIGENESIS, GENETIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HISTONE ACETYLTRANSFERASES; HUMANS; MICE; MICRORNAS; MUTATION; OSTEOCHONDRODYSPLASIAS; PROTEUS SYNDROME;

EID: 84940660940     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090314-045904     Document Type: Review

References (198)

1. Ahmad NN, Ala-Kokko L, Knowlton RG, Jimenez SA, Weaver EJ, et al. 1991. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). PNAS 88:6624-27
2. Akizu N, Silhavy JL, Rosti RO, Scott E, Fenstermaker AG, et al. 2014. Mutations in CSPP1 lead to classical Joubert syndrome. Am. J. Hum. Genet. 94:80-86
3. Al-DosariMS, Shaheen R, Colak D, Alkuraya FS. 2010. NovelCENPJmutation causes Seckel syndrome. J. Med. Genet. 47:411-14
4. Allen DB, Cuttler L. 2013. Short stature in childhood-challenges and choices. N. Engl. J. Med. 368:1220-28
5. Arboleda VA, Lee H, Parnaik R, Fleming A, Banerjee A, et al. 2012. Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome. Nat. Genet. 44:788-92
6. Arikawa-Hirasawa E, Watanabe H, Takami H, Hassell JR, Yamada Y. 1999. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23:354-58
7. Arikawa-Hirasawa E, WilcoxWR, Le AH, SilvermanN, Govindraj P, et al. 2001. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat. Genet. 27:431-34
8. Asharani PV, Keupp K, Semler O, Wang W, Li Y, et al. 2012. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am. J. Hum. Genet. 90:661-74
9. Baker S, Booth C, Fillman C, Shapiro M, Blair MP, et al. 2011. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome. Am. J. Med. Genet. A 155A:1668-72
10. Baldridge D, Shchelochkov O, Kelley B, Lee B. 2010. Signaling pathways in human skeletal dysplasias. Annu. Rev. Genomics Hum. Genet. 11:189-217
11. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, et al. 2011. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12:745-55
12. Bannister AJ, Kouzarides T. 2011. Regulation of chromatin by histonemodifications. Cell Res. 21:381-95
13. Baple EL, Chambers H, CrossHE, FawcettH,Nakazawa Y, et al. 2014. Hypomorphic PCNA mutation underlies a human DNA repair disorder. J. Clin. Investig. 124:3137-46
14. Bartels CF, Bukulmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, et al. 2004. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet. 75:27-34
15. Basten SG,Giles RH. 2013. Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis. Cilia 2:6
16. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, et al. 2013. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat. Genet. 45:1479-82
17. Beier F, Loeser RF. 2010. Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. J. Cell. Biochem. 110:573-80
18. Below JE, Earl DL, Shively KM, McMillin MJ, Smith JD, et al. 2013. Whole-genome analysis reveals that mutations in inositol polyphosphate phosphatase-like 1 cause opsismodysplasia. Am. J. Hum. Genet. 92:137-43
19. Bhaumik SR, Smith E, Shilatifard A. 2007. Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 14:1008-16
20. Bicknell LS, Bongers EM, Leitch A, Brown S, Schoots J, et al. 2011. Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat. Genet. 43:356-59
21. Bicknell LS, Walker S, Klingseisen A, Stiff T, Leitch A, et al. 2011. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat. Genet. 43:350-55
22. Biesecker L. 2006. The challenges of Proteus syndrome: diagnosis and management. Eur. J. Hum. Genet. 14:1151-57
23. Bonadio J, Jepsen KJ, MansouraMK, Jaenisch R, Kuhn JL, Goldstein SA. 1993. A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility. J. Clin. Investig. 92:1697-705
24. Bongers EM, Opitz JM, Fryer A, Sarda P, Hennekam RC, et al. 2001. Meier-Gorlin syndrome: report of eight additional cases and review. Am. J. Med. Genet. 102:115-24
25. Boyden ED, Campos-Xavier AB, Kalamajski S, Cameron TL, Suarez P, et al. 2011. Recurrent dominant mutations affecting two adjacent residues in the motor domain of the monomeric kinesin KIF22 result in skeletal dysplasia and joint laxity. Am. J. Hum. Genet. 89:767-72
26. Bredrup C, Saunier S, Oud MM, Fiskerstrand T, Hoischen A, et al. 2011. Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19. Am. J. Hum. Genet. 89:634-43
27. Bui C, Huber C, Tuysuz B, Alanay Y, Bole-Feysot C, et al. 2014. XYLT1 mutations in Desbuquois dysplasia type 2 Am. J. Hum. Genet. 94:405-14
28. Campeau PM, Kim JC, Lu JT, Schwartzentruber JA, Abdul-Rahman OA, et al. 2012. Mutations in KAT6B, encoding a histone acetyltransferase, cause genitopatellar syndrome. Am. J.Hum.Genet. 90:282-89
29. Campeau PM, Lenk GM, Lu JT, Bae Y, Burrage L, et al. 2013. Yunis-Varon syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase. Am. J. Hum. Genet. 92:781-91
30. Caux F, Plauchu H, Chibon F, Faivre L, Fain O, et al. 2007. Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur. J. Hum. Genet. 15:767-73
31. Celli J, van Bokhoven H, Brunner HG. 2003. Feingold syndrome: clinical review and genetic mapping. Am. J. Med. Genet. A 122A:294-300
32. Cho TJ, Lee KE, Lee SK, Song SJ, Kim KJ, et al. 2012. A single recurrent mutation in the 5-UTR of IFITM5 causes osteogenesis imperfecta type V. Am. J. Hum. Genet. 91:343-48
33. Clayton-Smith J,O'Sullivan J, Daly S, Bhaskar S,Day R, et al. 2011. Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome. Am. J. Hum. Genet. 89:675-81
34. Courtens W, Levi S, Verbelen F, Verloes A, Vamos E. 1997. Feingold syndrome: report of a new family and review. Am. J. Med. Genet. 73:55-60
35. Dauber A, Lafranchi SH, Maliga Z, Lui JC, Moon JE, et al. 2012. Novel microcephalic primordial dwarfism disorder associated with variants in the centrosomal protein ninein. J. Clin. Endocrinol. Metab. 97:E2140-51
36. Davis EE, Zhang Q, Liu Q, Diplas BH, Davey LM, et al. 2011. TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat. Genet. 43:189-96
37. de Munnik SA, Bicknell LS, Aftimos S, Al-Aama JY, van Bever Y, et al. 2012. Meier-Gorlin syndrome genotype-phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosis. Eur. J. Hum. Genet. 20:598-606
38. de Pontual L, Yao E, Callier P, Faivre L, Drouin V, et al. 2011. Germline deletion of the miR-17~92 cluster causes skeletal and growth defects in humans. Nat. Genet. 43:1026-30
39. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-21
40. Dickson LA, Pihlajaniemi T, Deak S, Pope FM, Nicholls A, et al. 1984. Nuclease S1 mapping of a homozygous mutation in the carboxyl-propeptide-coding region of the proα2(I) collagen gene in a patient with osteogenesis imperfecta. PNAS 81:4524-28
41. Dighe M, Fligner C, Cheng E, Warren B, Dubinsky T. 2008. Fetal skeletal dysplasia: an approach to diagnosis with illustrative cases. Radiographics 28:1061-77
42. Dowdle WE, Robinson JF, Kneist A, Sirerol-Piquer MS, Frints SG, et al. 2011. Disruption of a ciliary B9 protein complex causes Meckel syndrome. Am. J. Hum. Genet. 89:94-110
43. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-54
44. Edery P, Marcaillou C, Sahbatou M, Labalme A, Chastang J, et al. 2011. Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA. Science 332:240-43
45. Favaro FP, Alvizi L, Zechi-Ceide RM, Bertola D, Felix TM, et al. 2014. A noncoding expansion in EIF4A3 causes Richieri-Costa-Pereira syndrome, a craniofacial disorder associated with limb defects. Am. J. Hum. Genet. 94:120-28
46. FeingoldM,Hall BD, Lacassie Y,Martinez-Frias ML. 1997. Syndrome of microcephaly, facial and hand abnormalities, tracheoesophageal fistula, duodenal atresia, and developmental delay. Am. J. Med. Genet. 69:245-49
47. Ford-Hutchinson AF, Ali Z, Lines SE, Hallgrimsson B, Boyd SK, Jirik FR. 2007. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth. J. Bone Miner. Res. 22:1245-59
48. Francomano CA, Liberfarb RM, Hirose T, Maumenee IH, Streeten EA, et al. 1987. The Stickler syndrome: evidence for close linkage to the structural gene for type II collagen. Genomics 1:293-96
49. Francomano CA, Ortiz de Luna RI, Hefferon TW, Bellus GA, Turner CE, et al. 1994. Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p. Hum. Mol. Genet. 3:787-92
50. Fry AM, O'Regan L, Sabir SR, Bayliss R. 2012. Cell cycle regulation by the NEK family of protein kinases. J. Cell Sci. 125:4423-33
51. Gao B, Song H, Bishop K, Elliot G, Garrett L, et al. 2011. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev. Cell 20:163-76
52. Garbes L, Kim K, Riess A, Hoyer-Kuhn H, Beleggia F, et al. 2015. Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta. Am. J. Hum. Genet. 96:432-39
53. Garcia S, Dirat B, Tognacci T, Rochet N, Mouska X, et al. 2013. Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Sci. Transl. Med. 5:203ra124
54. Geister KA, Brinkmeier ML, Hsieh M, Faust SM, Karolyi IJ, et al. 2013. A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type. Hum. Mol. Genet. 22:345-57
55. Glazov EA, Zankl A, Donskoi M, Kenna TJ, Thomas GP, et al. 2011. Whole-exome re-sequencing in a family quartet identifies POP1 mutations as the cause of a novel skeletal dysplasia. PLOS Genet. 7:e1002027
56. Goetz SC, Anderson KV. 2010. The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet. 11:331-44
57. Goriely A,Wilkie AO. 2012. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am. J. Hum. Genet. 90:175-200
58. Griffith E,Walker S, Martin CA, Vagnarelli P, Stiff T, et al. 2008. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat. Genet. 40:232-36
59. Grosch M, Grüner B, Spranger S, St ützA,RauschT, et al. 2013. Identification of a ninein (NIN)mutation in a family with spondyloepimetaphyseal dysplasia with joint laxity (leptodactylic type)-like phenotype. Matrix Biol. 32:387-92
60. Growth Horm. Res. Soc. 2000. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J. Clin. Endocrinol. Metab. 85:3990-93
61. Guernsey DL,MatsuokaM, JiangH,Evans S, MacgillivrayC, et al. 2011. Mutations in origin recognition complex gene ORC4 cause Meier-Gorlin syndrome. Nat. Genet. 43:360-64
62. Halbritter J, Bizet AA, Schmidts M, Porath JD, Braun DA, et al. 2013. Defects in the IFT-B component IFT172 cause Jeune and Mainzer-Saldino syndromes in humans. Am. J. Hum. Genet. 93:915-25
63. Happle R. 1987. Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J. Am. Acad. Dermatol. 16:899-906
64. He H, Liyanarachchi S, Akagi K, Nagy R, Li J, et al. 2011. Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I. Science 332:238-40
65. Hemerly AS, Prasanth SG, Siddiqui K, Stillman B. 2009. Orc1 controls centriole and centrosome copy number in human cells. Science 323:789-93
66. Hiramatsu K, Sasagawa S, Outani H, Nakagawa K, Yoshikawa H, Tsumaki N. 2011. Generation of hyaline cartilaginous tissue frommouse adult dermal fibroblast culture by defined factors. J. Clin. Investig. 121:640-57
67. Hirata M, Kugimiya F, Fukai A, Ohba S, Kawamura N, et al. 2009. C/EBPβpromotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57Kip2. PLOS ONE 4:e4543
68. Hoover-Fong J, Sobreira N, Jurgens J, Modaff P, Blout C, et al. 2014. Mutations in PCYT1A, encoding a key regulator of phosphatidylcholine metabolism, cause spondylometaphyseal dysplasia with cone-rod dystrophy. Am. J. Hum. Genet. 94:105-12
69. Horton WA, Hall JG, Hecht JT. 2007. Achondroplasia. Lancet 370:162-72
70. Hossain M, Stillman B. 2012. Meier-Gorlin syndrome mutations disrupt an Orc1 CDK inhibitory domain and cause centrosome reduplication. Genes Dev. 26:1797-810
71. Hsieh SC, Chen NT, Lo SH. 2009. Conditional loss of PTEN leads to skeletal abnormalities and lipoma formation. Mol. Carcinog. 48:545-52
72. Huber C, Cormier-Daire V. 2012. Ciliary disorder of the skeleton. Am. J. Med. Genet. C 160C:165-74
73. Huber C, Faqeih EA, Bartholdi D, Bole-Feysot C, Borochowitz Z, et al. 2013. Exome sequencing identifies INPPL1 mutations as a cause of opsismodysplasia. Am. J. Hum. Genet. 92:144-49
74. Huber C,Wu S, Kim AS, Sigaudy S, Sarukhanov A, et al. 2013. WDR34 mutations that cause short-rib polydactyly syndrome type III/severe asphyxiating thoracic dysplasia reveal a role for the NF-κB pathway in cilia. Am. J. Hum. Genet. 93:926-31
75. Ikegami D, Akiyama H, Suzuki A, Nakamura T, Nakano T, et al. 2011. Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 138:1507-19
76. Ishikawa H, Marshall WF. 2011. Ciliogenesis: building the cell's antenna. Nat. Rev. Mol. Cell Biol. 12:222-34
77. Jin M, Yu Y, Qi H, Xie Y, Su N, et al. 2012. A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia. Hum. Mol. Genet. 21:5443-55
78. Jonquoy A, Mugniery E, Benoist-Lasselin C, Kaci N, Le Corre L, et al. 2012. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model. Hum. Mol. Genet. 21:841-51
79. Kalay E, Yigit G, Aslan Y, Brown KE, Pohl E, et al. 2011. CEP152 is a genome maintenance protein disrupted in Seckel syndrome. Nat. Genet. 43:23-26
80. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, et al. 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8:277-89
81. Karsenty G, Kronenberg HM, Settembre C. 2009. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25:629-48
82. Kawasaki Y, Kugimiya F, Chikuda H, Kamekura S, Ikeda T, et al. 2008. Phosphorylation of GSK-3β by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J. Clin. Investig. 118:2506-15
83. Keupp K, Beleggia F,Kayserili H, Barnes AM, Steiner M, et al. 2013. Mutations inWNT1cause different forms of bone fragility. Am. J. Hum. Genet. 92:565-74
84. Klingseisen A, Jackson AP. 2011. Mechanisms and pathways of growth failure in primordial dwarfism. Genes Dev. 25:2011-24
85. Knoblich JA. 2010. Asymmetric cell division: recent developments and their implications for tumour biology. Nat. Rev. Mol. Cell Biol. 11:849-60
86. Krakow D, Rimoin DL. 2010. The skeletal dysplasias. Genet Med. 12:327-41
87. Krejci P, Masri B, Fontaine V,Mekikian PB,WeisM, et al. 2005. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J. Cell Sci. 118:5089-100
88. Kronenberg HM. 2003. Developmental regulation of the growth plate. Nature 423:332-36
89. Kronenberg HM. 2006. PTHrP and skeletal development. Ann. N.Y. Acad. Sci. 1068:1-13
90. Kuo AJ, Song J, Cheung P, Ishibe-Murakami S, Yamazoe S, et al. 2012. The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome. Nature 484:115-19
91. Lachman RS, Tiller GE, Graham JM Jr, Rimoin DL. 1992. Collagen, genes and the skeletal dysplasias on the edge of a new era: a review and update. Eur. J. Radiol. 14:1-10
92. Lango AllenH, Estrada K, LettreG, Berndt SI, Weedon MN, et al. 2010. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467:832-38
93. Le Goff C, Mahaut C, Abhyankar A, Le Goff W, Serre V, et al. 2012. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat. Genet. 44:85-88
94. Le Goff C, Mahaut C, Wang LW, Allali S, Abhyankar A, et al. 2011. Mutations in the TGFβbindingprotein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am. J. Hum. Genet. 89:7-14
95. Le MerrerM, Rousseau F, Legeai-Mallet L, Landais JC, Pelet A, et al. 1994. A gene for achondroplasiahypochondroplasia maps to chromosome 4p. Nat. Genet. 6:318-21
96. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, Baldini A, et al. 1997. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16:307-10
97. Lee B, Vissing H, Ramirez F, Rogers D, Rimoin D. 1989. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. Science 244:978-80
98. Lee H, Graham JM Jr, Rimoin DL, Lachman RS, Krejci P, et al. 2012. Exome sequencing identifies PDE4D mutations in acrodysostosis. Am. J. Hum. Genet. 90:746-51
99. Li Y, Dudley AT. 2009. Noncanonical frizzled signaling regulates cell polarity of growth plate chondrocytes. Development 136:1083-92
100. Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, et al. 2011. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N. Engl. J. Med. 365:611-19
101. Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, et al. 2011. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N. Engl. J. Med. 364:2218-26
102. Lorget F, Kaci N, Peng J, Benoist-Lasselin C, Mugniery E, et al. 2012. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia. Am. J. Hum. Genet. 91:1108-14
103. Marini JC, Blissett AR. 2013. New genes in bone development: what's new in osteogenesis imperfecta. J. Clin. Endocrinol. Metab. 98:3095-103
104. Martin CA, Ahmad I, Klingseisen A,Hussain MS, Bicknell LS, et al. 2014. Mutations in PLK4, encoding a master regulator of centriole biogenesis, cause microcephaly, growth failure and retinopathy. Nat. Genet. 46:1283-92
105. Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M, Temtamy S, et al. 2012. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum. Mutat. 33:343-50
106. Matsushita M, Kitoh H, Ohkawara B, Mishima K, Kaneko H, et al. 2013. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia. PLOS ONE 8:e81569
107. McInerney-Leo AM, Schmidts M, Cortes CR, Leo PJ, Gener B, et al. 2013. Short-rib polydactyly and Jeune syndromes are caused by mutations in WDR60. Am. J. Hum. Genet. 93:515-23
108. Mehawej C, Delahodde A, Legeai-Mallet L, Delague V, Kaci N, et al. 2014. The impairment of MAGMAS function in human is responsible for a severe skeletal dysplasia. PLOS Genet. 10:e1004311
109. Merrill AE, Sarukhanov A, Krejci P, Idoni B, CamachoN, et al. 2012. Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling. Am. J. Hum. Genet. 90:550-57
110. Metzker ML. 2010. Sequencing technologies\-The next generation. Nat. Rev. Genet. 11:31-46
111. Michot C, Le Goff C, Goldenberg A, Abhyankar A, Klein C, et al. 2012. Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am. J. Hum. Genet. 90:740-45
112. Mill P, Lockhart PJ, Fitzpatrick E, Mountford HS, Hall EA, et al. 2011. Human and mouse mutations in WDR35 cause short-rib polydactyly syndromes due to abnormal ciliogenesis. Am. J. Hum. Genet. 88:508-15
113. Min BJ, Kim N, Chung T, Kim OH, Nishimura G, et al. 2011. Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type. Am. J. Hum. Genet. 89:760-66
114. Mirzaa GM, Vitre B, Carpenter G, Abramowicz I, Gleeson JG, et al. 2014. Mutations in CENPE define a novel kinetochore-centromeric mechanism for microcephalic primordial dwarfism. Hum. Genet. 133:1023-39
115. Moens CB, Auerbach AB, Conlon RA, Joyner AL, Rossant J. 1992. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 6:691-704
116. Mohamed JY, Faqeih E, Alsiddiky A, Alshammari MJ, Ibrahim NA, Alkuraya FS. 2013. Mutations in MEOX1, encoding mesenchyme homeobox 1, cause Klippel-Feil anomaly. Am. J.Hum.Genet. 92:157-61
117. Muenzer J. 2014. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses. Mol. Genet. Metab. 111:63-72
118. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, et al. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-79
119. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, de Crombrugghe B. 2004. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 18:290-305
120. Murray JE, van der Burg M, IJspeertH,Carroll P,WuQ, et al. 2015. Mutations in the NHEJ component XRCC4 cause primordial dwarfism. Am. J. Hum. Genet. 96:412-24
121. Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, et al. 1998. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 8:661-64
122. Nicole S, Davoine CS, TopalogluH, Cattolico L, BarralD, et al. 2000. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat. Genet. 26:480-83
123. Nigg EA, Stearns T. 2011. The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries. Nat. Cell Biol. 13:1154-60
124. Nundlall S, Rajpar MH, Bell PA, Clowes C, Zeeff LA, et al. 2010. An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. Cell Stress Chaperones 15:835-49
125. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33:497-501
126. Ogi T, Walker S, Stiff T, Hobson E, Limsirichaikul S, et al. 2012. Identification of the first ATRIPdeficient patient and novel mutations in ATR define a clinical spectrum for ATR-ATRIP Seckel syndrome. PLOS Genet. 8:e1002945
127. Okada M, Ikegawa S, Morioka M, Yamashita A, Saito A, et al. 2015. Modeling type II collagenopathy skeletal dysplasia by directed conversion and induced pluripotent stem cells. Hum. Mol. Genet. 24:299-313
128. Ota S, Zhou ZQ, Keene DR, Knoepfler P, Hurlin PJ. 2007. Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development 134:1583-92
129. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-71
130. Outani H, Okada M, Hiramatsu K, Yoshikawa H, Tsumaki N. 2011. Induction of chondrogenic cells from dermal fibroblast culture by defined factors does not involve a pluripotent state. Biochem. Biophys. Res. Commun. 411:607-12
131. Outani H, Okada M, Yamashita A, Nakagawa K, Yoshikawa H, Tsumaki N. 2013. Direct induction of chondrogenic cells from human dermal fibroblast culture by defined factors. PLOS ONE 8:e77365
132. Pansuriya TC, van Eijk R, d'Adamo P, van Ruler MA, Kuijjer ML, et al. 2011. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat. Genet. 43:1256-61
133. Payne F, Colnaghi R, Rocha N, Seth A, Harris J, et al. 2014. Hypomorphism in human NSMCE2 linked to primordial dwarfism and insulin resistance. J. Clin. Investig. 124:4028-38
134. Perrault I, Saunier S, Hanein S, Filhol E, Bizet AA, et al. 2012. Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations. Am. J. Hum. Genet. 90:864-70
135. Piel M, Meyer P,Khodjakov A, Rieder CL, Bornens M. 2000. The respective contributions of themother and daughter centrioles to centrosome activity and behavior in vertebrate cells. J. Cell Biol. 149:317-30
136. Pihlajaniemi T, Dickson LA, Pope FM, Korhonen VR, Nicholls A, et al. 1984. Osteogenesis imperfecta: cloning of a pro-α2(I) collagen gene with a frameshift mutation. J. Biol. Chem. 259:12941-44
137. Qvist P, Huertas P, Jimeno S, Nyegaard M, Hassan MJ, et al. 2011. CtIP mutations cause Seckel and Jawad syndromes. PLOS Genet. 7:e1002310
138. Rajpar MH, McDermott B, Kung L, Eardley R, Knowles L, et al. 2009. Targeted induction of endoplasmic reticulum stress induces cartilage pathology. PLOS Genet. 5:e1000691
139. Rauch A, Thiel CT, Schindler D, Wick U, Crow YJ, et al. 2008. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science 319:816-19
140. Rios JJ, Paria N, Burns DK, Israel BA, Cornelia R, et al. 2013. Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly. Hum. Mol. Genet. 22:444-51
141. Romereim SM,Conoan NH, Chen B, Dudley AT. 2014. A dynamic cell adhesion surface regulates tissue architecture in growth plate cartilage. Development 141:2085-95
142. Romereim SM,Dudley AT. 2011. Cell polarity: themissing link in skeletalmorphogenesis? Organogenesis 7:217-28
143. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, et al. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-54
144. Sarig O, Nahum S, Rapaport D, Ishida-Yamamoto A, Fuchs-Telem D, et al. 2012. Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutation. Am. J. Hum. Genet. 91:337-42
145. Savarirayan R, Rimoin DL. 2002. The skeletal dysplasias. Best Pract. Res. Clin. Endocrinol. Metab. 16:547-60
146. Schmidts M, Vodopiutz J, Christou-Savina S, Cortes CR, McInerney-Leo AM, et al. 2013. Mutations in the gene encoding IFT dynein complex component WDR34 cause Jeune asphyxiating thoracic dystrophy. Am. J. Hum. Genet. 93:932-44
147. Schreml J, Durmaz B, Cogulu O, Keupp K, Beleggia F, et al. 2014. The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation. Hum. Genet. 133:29-39
148. Semler O, Garbes L, Keupp K, Swan D, Zimmermann K, et al. 2012. A mutation in the 5-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am. J. Hum. Genet. 91:349-57
149. Shaheen R, Al Tala S, Almoisheer A, Alkuraya FS. 2014. Mutation in PLK4, encoding a master regulator of centriole formation, defines a novel locus for primordial dwarfism. J. Med. Genet. 51:814-16
150. Shaheen R, AlazamiAM, Alshammari MJ, FaqeihE,AlhashmiN, et al. 2012. Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation. J. Med. Genet. 49:630-35
151. Shaheen R, Faqeih E, Shamseldin HE, Noche RR, Sunker A, et al. 2012. POC1A truncation mutation causes a ciliopathy in humans characterized by primordial dwarfism. Am. J. Hum. Genet. 91:330-36
152. Shaheen R, Schmidts M, Faqeih E, Hashem A, Lausch E, et al. 2015. A founder CEP120 mutation in Jeune asphyxiating thoracic dystrophy expands the role of centriolar proteins in skeletal ciliopathies. Hum. Mol. Genet. 24:1410-19
153. Shaheen R, Shamseldin HE, Loucks CM, Seidahmed MZ, Ansari S, et al. 2014. Mutations in CSPP1, encoding a core centrosomal protein, cause a range of ciliopathy phenotypes in humans. Am. J. Hum. Genet. 94:73-79
154. Shamseldin HE,Rajab A, Alhashem A, Shaheen R, Al-Shidi T, et al. 2013. Mutations in DDX59 implicate RNA helicase in the pathogenesis of orofaciodigital syndrome. Am. J. Hum. Genet. 93:555-60
155. ShiangR,ThompsonLM, ZhuYZ, ChurchDM,Fielder TJ, et al. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-42
156. Shukla V, Coumoul X, Wang RH, KimHS, Deng CX. 2007. RNA interference and inhibition of MEKERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nat. Genet. 39:1145-50
157. Smits P, Bolton AD, Funari V, Hong M, Boyden ED, et al. 2010. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N. Engl. J. Med. 362:206-16
158. Song B, Haycraft CJ, Seo HS, Yoder BK, Serra R. 2007. Development of the post-natal growth plate requires intraflagellar transport proteins. Dev. Biol. 305:202-16
159. Stiff T, Alagoz M, Alcantara D, Outwin E, Brunner HG, et al. 2013. Deficiency in origin licensing proteins impairs cilia formation: implications for the aetiology of Meier-Gorlin syndrome. PLOS Genet. 9:e1003360
160. Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM, Lee SJ. 1994. Limb alterations in brachypodism mice due to mutations in a new member of the TGFβ-superfamily. Nature 368:639-43
161. Stray-Pedersen A, Backe PH, Sorte HS, Morkrid L, Chokshi NY, et al. 2014. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am. J. Hum. Genet. 95:96-107
162. Symoens S, Malfait F, D'Hondt S, Callewaert B, Dheedene A, et al. 2013. Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans. Orphanet J. Rare Dis. 8:154
163. Thiel C, Kessler K, Giessl A, Dimmler A, Shalev SA, et al. 2011. NEK1 mutations cause short-rib polydactyly syndrome type Majewski. Am. J. Hum. Genet. 88:106-14
164. Thomas S, Legendre M, Saunier S, Bessieres B, Alby C, et al. 2012. TCTN3 mutations cause Mohr-Majewski syndrome. Am. J. Hum. Genet. 91:372-78
165. Tsang KY, Chan D, Cheslett D, Chan WC, So CL, et al. 2007. Surviving endoplasmic reticulum stress is coupled to altered chondrocyte differentiation and function. PLOS Biol. 5:e44
166. Tsipouras P, Myers JC, Ramirez F, Prockop DJ. 1983. Restriction fragment length polymorphism associated with the proα2(I) gene of human type I procollagen: application to a family with an autosomal dominant form of osteogenesis imperfecta. J. Clin. Investig. 72:1262-67
167. Tunkel D, Alade Y, Kerbavaz R, Smith B, Rose-Hardison D, Hoover-Fong J. 2012. Hearing loss in skeletal dysplasia patients. Am. J. Med. Genet. A 158A:1551-55
168. Tuz K, Bachmann-Gagescu R, O'Day DR, Hua K, Isabella CR, et al. 2014. Mutations in CSPP1 cause primary cilia abnormalities and Joubert syndrome with or without Jeune asphyxiating thoracic dystrophy. Am. J. Hum. Genet. 94:62-72
169. Ulici V, James CG, Hoenselaar KD, Beier F. 2010. Regulation of gene expression by PI3K in mouse growth plate chondrocytes. PLOS ONE 5:e8866
170. Unlu G, Levic DS, Melville DB, Knapik EW. 2014. Trafficking mechanisms of extracellular matrix macromolecules: insights from vertebrate development and human diseases. Int. J. Biochem. Cell Biol. 47:57-67
171. Valente EM, Logan CV, Mougou-Zerelli S, Lee JH, Silhavy JL, et al. 2010. Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes. Nat. Genet. 42:619-25
172. van Bokhoven H, Celli J, van Reeuwijk J, Rinne T, Glaudemans B, et al. 2005. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat. Genet. 37:465-67
173. Velinov M, Slaugenhaupt SA, Stoilov I, Scott CI Jr, Gusella JF, Tsipouras P. 1994. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nat. Genet. 6:314-17
174. Venoux M, Tait X, Hames RS, Straatman KR, Woodland HR, Fry AM. 2013. Poc1A and Poc1B act together in human cells to ensure centriole integrity. J. Cell Sci. 126:163-75
175. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132:875-86
176. Vilain E, Le MerrerM, Lecointre C, Desangles F,Kay MA, et al. 1999. IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. J. Clin. Endocrinol. Metab. 84:4335-40
177. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. 1996. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-22
178. Wallingford JB, Mitchell B. 2011. Strange as it may seem: the many links between Wnt signaling, planar cell polarity, and cilia. Genes Dev. 25:201-13
179. WangB, Sinha T, Jiao K, Serra R,Wang J. 2011. Disruption ofPCPsignaling causes limbmorphogenesis and skeletal defects and may underlie Robinow syndrome and brachydactyly type B. Hum. Mol. Genet. 20:271-85
180. Wang X, Tsai JW, Imai JH, Lian WN, Vallee RB, Shi SH. 2009. Asymmetric centrosome inheritance maintains neural progenitors in the neocortex. Nature 461:947-55
181. Wang Y, Wysocka J, Perlin JR, Leonelli L, Allis CD, Coonrod SA. 2004. Linking covalent histone modifications to epigenetics: the rigidity and plasticity of the marks. Cold Spring Harb. Symp. Quant. Biol. 69:161-69
182. Warman ML, Cormier-Daire V,Hall C, Krakow D, Lachman R, et al. 2011. Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. A 155A:943-68
183. Webster MK, D'Avis PY, Robertson SC, Donoghue DJ. 1996. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol. Cell. Biol. 16:4081-87
184. WebsterMK, Donoghue DJ. 1996. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15:520-27
185. Weinstein LS, Shenker A, Gejman PV,MerinoMJ, Friedman E, Spiegel AM. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325:1688-95
186. Wendt DJ, Dvorak-Ewell M, Bullens S, Lorget F, Bell SM, et al. 2015. Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism. J. Pharmacol. Exp. Ther. 353:132-49
187. Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, et al. 2010. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am. J. Hum. Genet. 87:219-28
188. Wood AR, Esko T, Yang J, Vedantam S, Pers TH, et al. 2014. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46:1173-86
189. Xie Y, Su N, Jin M, Qi H, Yang J, et al. 2012. Intermittent PTH (1-34) injection rescues the retarded skeletal development and postnatal lethality ofmice mimicking human achondroplasia and thanatophoric dysplasia. Hum. Mol. Genet. 21:3941-55
190. Yamamoto GL, Baratela WA, Almeida TF, Lazar M, Afonso CL, et al. 2014. Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod dystrophy. Am. J. Hum. Genet. 94:113-19
191. Yamashita A, Morioka M, Kishi H, Kimura T, Yahara Y, et al. 2014. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Nature 513:507-11
192. Yang G, Sun Q, Teng Y, Li F, Weng T, Yang X. 2008. PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1αsignaling and endoplasmic reticulum stress. Development 135:3587-97
193. Yang G, Zhu L, Hou N, Lan Y, Wu XM, et al. 2014. Osteogenic fate of hypertrophic chondrocytes. Cell Res. 24:1266-69
194. Yang L, Tsang KY, Tang HC, Chan D, Cheah KS. 2014. Hypertrophic chondrocytes can become osteoblasts and osteocytes in endochondral bone formation. PNAS 111:12097-102
195. Yasoda A, Kitamura H, Fujii T, Kondo E, Murao N, et al. 2009. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology 150:3138-44
196. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, et al. 2004. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10:80-86
197. Yasoda A, Nakao K. 2010. Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias. Endocr. J. 57:659-66
198. Zhou X, von der Mark K, Henry S, Norton W, Adams H, de Crombrugghe B. 2014. Chondrocytes transdifferentiate into osteoblasts in endochondral bone during development, postnatal growth and fracture healing in mice. PLOS Genet. 10:e1004820